Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
novel GmbH Address & Contact
novel GmbH at a Glance
The novel GmbH from Munich in Bavaria is a leading company in the field of pressure distribution measurement and gait analysis. Since its foundation, the company has specialized in the development and production of innovative pressure measurement systems that enable biomechanical analysis of step pressure, stance, and movement. These technologies are particularly used in orthopedics, sports medicine, and neurology, significantly contributing to the improvement of diagnoses and therapies.
The novel GmbH has established itself not only as a pioneer in the field of pressure measurement but also as a reliable partner for professionals engaged in biomechanical research and clinical application. The company's innovative products are the result of continuous research and development as well as close collaboration with scientists and practitioners in the field of medicine.
Services and Products
The product portfolio of novel includes various system solutions tailored to the specific needs in the health and sports sector. Outstanding are:
- pedar-System: A highly developed system for dynamic insole measurement that captures and analyzes the pressure under the foot in real-time. It is mainly used in insole provision and for analyzing movement patterns.
- emed-Plattform: This platform allows for precise stance measurements and is primarily used in sports traumatology. It provides valuable information on stability and force distribution while standing and moving.
- loadsol-System: A mobile gait analysis solution that enables the capture of gait profiles under normal everyday conditions. This system is particularly used in neuro-rehabilitation as well as in research projects and clinical studies.
The systems of novel are not only in use in Germany but also worldwide in over 50 countries and have made a name for themselves in the industry due to their reliability and precision. In particular, in the field of rehabilitation and orthopedic diagnostics, the products have become indispensable as they provide an objective data basis for treatment decisions.
Regulatory Classification
As a manufacturer of medical technology, novel GmbH is subject to strict regulatory requirements. The products of novel GmbH are CE certified, meaning they meet the relevant health and safety requirements of the European Union. This is crucial for ensuring the safety and effectiveness of the products in clinical operation. Furthermore, the company is continuously working to meet and exceed the requirements of ISO standards as well as the MDR (Medical Device Regulation) to ensure the highest quality standards for its customers.
Regional Significance
Munich as the location for novel GmbH brings numerous advantages. The city is not only a center for medical technology and life sciences but also has excellent educational institutions such as the Technical University of Munich and the LMU Hospital. These institutions are not only important cooperation partners but also significant sources of research and innovation. Through close cooperation with universities and research institutes, novel GmbH can continually stay at the forefront of technological developments and incorporate new scientific findings into product development.
In addition, the region is a hotspot for professional conferences and networks that allow novel GmbH to expand its expertise, build partnerships, and stay informed about the latest trends in medical technology.
Special Features of novel GmbH
A distinctive feature of novel GmbH is the combination of innovative technology and practical application. Through practice-oriented research, it is ensured that the products are not only technically advanced but also user-friendly and effective. Furthermore, novel GmbH offers comprehensive training and support for its products, enabling professionals to optimally utilize the systems and effectively integrate the data gained into their therapeutic work.
The innovative strength of novel is reinforced by a high proportion of research and development expenditure, enabling the company to develop new products and continuously improve existing technologies to meet the changing demands of the industry.
Other medical technology companies: Medical Technology Overview | Sanitation Stores | Pharmaceutical Companies
```Frequently asked questions about novel GmbH
What does novel GmbH do?
novel GmbH is a company in the medical technology sector based in München. The company develops, produces or distributes medical devices, instruments or systems for use in healthcare facilities.
Where is novel GmbH located?
novel GmbH is headquartered in München. More information can be found on the company's website.
In which area of medical technology is novel GmbH active?
novel GmbH is active in the medical technology sector and offers solutions for medical facilities, clinics and practices. You can find the exact areas of focus on the company's website.
More Medical Technology in München
Medical Technology in Germany
Related areas in healthcare
Medical Technology by location
About Medical Technology
Germany's medical technology sector is one of the most important in the world. With annual revenues of approximately EUR 36 billion and more than 1,400 companies, Germany ranks as the third-largest medical technology market globally (SPECTARIS 2023), after the United States and Japan. The sector encompasses the development, manufacture and distribution of an extraordinarily wide range of products: in-vitro diagnostic (IVD) devices, medical imaging systems (CT, MRI, ultrasound), implants such as hip and knee prostheses, cardiac pacemakers, surgical instruments, hospital beds, wound care products and medical software classified as a Software as a Medical Device (SaMD). In Germany and across the European Union, medical devices must comply with the EU Medical Device Regulation (MDR 2017/745), which replaced the former Medical Devices Directive (MDD 93/42/EEC). Devices are classified into risk classes I, IIa, IIb and III. Higher-risk classes require a conformity assessment by a designated Notified Body (benannte Stelle) before a CE mark can be affixed. The CE mark signals that the product meets EU safety, performance and quality requirements and may be placed on the European market. Key medtech clusters in Germany include the Munich and Nuremberg region in Bavaria, the Rhine-Main area in Hesse, Tuttlingen in Baden-Württemberg (known as the world capital of surgical instruments) and the Hamburg metropolitan area. This directory lists CE-certified manufacturers, distributors and suppliers across the German medtech sector with full contact details.
Germany as a Global Medical Technology Hub
Germany's position as the world's third-largest medical technology market is underpinned by a combination of industrial engineering excellence, a well-funded healthcare system and a highly productive research landscape. The German medtech sector is characterised by a large number of small and medium-sized enterprises (SMEs) that are often hidden champions (Weltmarktführer) in specialised niches. Unlike the pharmaceutical sector, where large corporations dominate, the medtech industry is more fragmented and innovative, with frequent spin-offs from university hospitals and engineering faculties. Key product categories include imaging systems (MRI, CT, X-ray, ultrasound), endoscopy and minimally invasive surgical tools, orthopaedic implants, cardiovascular devices, in-vitro diagnostics, dental equipment, ophthalmic devices, wound care systems and hospital IT and medical software. Germany is particularly renowned for its surgical instrument manufacturing, centred in Tuttlingen, Baden-Württemberg, which supplies operating theatres worldwide. The annual Medica trade fair in Düsseldorf is the world's largest medical technology exhibition and serves as a global industry showcase.
EU MDR Compliance and CE Marking for German Manufacturers
The EU Medical Device Regulation (MDR 2017/745) replaced the former Medical Devices Directive (MDD 93/42/EEC) and has applied in full since May 2021, with transition periods for legacy devices extended to 2028 in some cases. For German manufacturers selling in the EU market, MDR compliance is a legal necessity. The regulation introduced significantly strengthened requirements compared to the old MDD: more rigorous clinical evidence requirements, mandatory post-market clinical follow-up (PMCF), unique device identification (UDI) registration in the EUDAMED database, increased obligations for Notified Bodies, and stricter rules for software as a medical device (SaMD). The risk classification system under MDR uses four classes (I, IIa, IIb, III) based on the intended purpose, duration of use and body contact of the device. Manufacturers must appoint an authorised representative in the EU if they are not themselves based in an EU member state, and they must maintain a quality management system. In Germany, the Bundesnetzagentur and state authorities support MDR enforcement alongside BfArM.
Innovation and Research in German Medtech
Germany's medtech innovation ecosystem benefits from close collaboration between industry, university hospitals (Universitätsklinika), applied research institutes (such as those of the Fraunhofer and Helmholtz networks) and health technology assessment bodies. The Federal Joint Committee (Gemeinsamer Bundesausschuss, G-BA) and the Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) play important roles in assessing which new medical technologies are eligible for reimbursement by statutory health insurance (GKV). This reimbursement pathway, known as the NUB process (Neue Untersuchungs- und Behandlungsmethoden) for hospital technologies, is a key milestone for commercial success in Germany. Innovative devices that receive a positive NUB assessment can be reimbursed at negotiated rates by statutory insurers, providing a significant market access advantage.
Innovation Fields and Future Technologies
The German medical technology sector is driving numerous future fields forward. AI-supported diagnostics and image analysis are revolutionising radiology and pathology; algorithms for the early detection of cancer and cardiovascular disease are increasingly receiving CE approvals as Software as a Medical Device (SaMD). Robot-assisted surgical systems, led by products from Siemens Healthineers, Brainlab and Karl Storz, are improving precision in complex procedures. Minimally invasive technologies, implantable pacemakers and intelligent prostheses with sensory feedback demonstrate the breadth of innovation. Point-of-care diagnostics enables rapid tests directly in the doctor's surgery or at the bedside. Telemedicine and digital patient records promote networking between medical devices and clinical workflows. The Federal Ministry of Education and Research (BMBF) funding programme specifically supports the development of innovative medical technology products through cooperation between industry and universities.
What does the medical technology sector cover?
Medical technology encompasses the development, manufacture and distribution of medical devices, instruments, software and accessories used to diagnose, prevent, monitor or treat diseases. Germany ranks among the world's leading medical technology hubs.
How are medical devices approved in Germany?
Medical devices in Germany and the EU must comply with the EU Medical Device Regulation (MDR 2017/745) and carry the CE mark. Depending on the risk class, conformity assessments by notified bodies are required.
Where can I find medical technology companies in Germany?
Medical technology companies in Germany can be found through industry associations such as SPECTARIS, BVMed or ZVEI, and via the EUDAMED EU database for registered manufacturers. Sanoliste provides a searchable directory of manufacturers, distributors and suppliers across the German medical technology sector.
How many medical technology companies are there in Germany?
Germany has more than 1,400 medical technology companies generating annual revenues of approximately EUR 36 billion (SPECTARIS 2023), making it the third-largest medical technology market in the world. The majority of companies are small and medium-sized enterprises (SMEs), many of which are world market leaders in their niche.
What are the risk classes for medical devices under the EU MDR?
The EU Medical Device Regulation (MDR 2017/745) classifies medical devices into four risk classes: Class I (lowest risk, e.g. bandages, glasses frames), Class IIa (medium risk, e.g. hearing aids, contact lenses), Class IIb (higher medium risk, e.g. infusion pumps, ventilators) and Class III (highest risk, e.g. implantable cardiac devices, neurosurgical instruments). Higher classes require more rigorous conformity assessment by a Notified Body.
Where are the main medical technology clusters in Germany?
Germany's medical technology industry is concentrated in several regional clusters. Bavaria (particularly Munich and Nuremberg) and Baden-Württemberg (notably Tuttlingen, globally known for surgical instruments) are the two strongest regions. Other significant clusters include the Rhine-Main area in Hesse, the Hamburg metropolitan region, the Ruhr area in North Rhine-Westphalia and the Berlin-Brandenburg region.
What is a Notified Body (benannte Stelle) and why does it matter?
A Notified Body (benannte Stelle) is an independent third-party organisation designated by an EU member state to assess whether medical devices meet the requirements of the MDR before they can carry the CE mark. For Class IIa, IIb and III devices, manufacturers must have their quality management system and technical documentation assessed by a Notified Body. In Germany, the Federal Institute for Drugs and Medical Devices (BfArM) oversees market surveillance, while several German organisations hold Notified Body status under the MDR.